Harrow CEO tries to defend 486% price hike of eye medication ...Middle East

Quartz - Economy
Harrow CEO tries to defend 486% price hike of eye medication
At least 945 brand name drugs have had their list prices hiked in 2024 so far, according to the non-profit 46Brooklyn. One of the largest was Harrow’s eye medication Triesence at a 486% increase to $944 from $161.Read more...

Hence then, the article about harrow ceo tries to defend 486 price hike of eye medication was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Harrow CEO tries to defend 486% price hike of eye medication )

Apple Storegoogle play

Last updated :

Also on site :



Latest News